Proteomic Profiling of Hypoplastic Lungs Suggests an Underlying Inflammatory Response in the Pathogenesis of Abnormal

Richard Wagner1,2,3,4, Paula Lieckfeldt1,2,3,4, Hadeesha Piyadasa3,5,6

  • 1Departments of Surgery, Division of Pediatric Surgery, Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, Canada.

Annals of Surgery
|August 3, 2022
PubMed

Insights

Congenital diaphragmatic hernia (CDH) causes abnormal lung development. This study found inflammatory pathways, particularly STAT3 signaling, are key to lung hypoplasia in CDH, offering new therapeutic targets.

Area of Science:

  • Developmental Biology
  • Proteomics
  • Neonatal Pathology

Background:

  • Congenital diaphragmatic hernia (CDH) is a severe birth defect characterized by abnormal lung development and high mortality.
  • The precise mechanisms driving lung hypoplasia in CDH remain poorly understood, hindering effective treatment strategies.

Purpose of the Study:

  • To investigate the proteomic differences in fetal lungs affected by CDH compared to controls.
  • To identify key molecular pathways and proteins involved in the pathogenesis of CDH-induced lung hypoplasia.
  • To explore potential therapeutic targets for improving lung development in CDH.

Main Methods:

  • Comparative proteomic analysis of fetal rat lungs exposed to nitrofen (CDH model) versus vehicle controls.
  • Pathway analysis to identify enriched biological processes in CDH lungs.
  • Immunohistochemical analysis of Tenascin C and STAT3 expression in rat and human CDH lungs.
  • Ex vivo experiments using fetal rat lung explants to assess the effect of STAT3 inhibition.
  • Analysis of cytokine levels in fetal tracheal aspirates from CDH patients.

Main Results:

  • Proteomic analysis revealed significant enrichment of inflammatory response proteins, including cytokine signaling and Epstein Barr Virus pathways, in nitrofen-induced CDH lungs.
  • Tenascin C was decreased, while STAT3 was significantly increased in the airway epithelium of CDH lungs.
  • STAT3 inhibition partially rescued the lung hypoplasia phenotype ex vivo, promoting peripheral lung budding.
  • Elevated levels of STAT3-associated cytokines (IL-15, IL-9, IL-2) were observed in CDH survivors' tracheal aspirates.

Conclusions:

  • Downstream inflammatory processes, driven by STAT3 signaling, are critically involved in the pathogenesis of abnormal lung development in CDH.
  • Targeting STAT3 signaling presents a potential therapeutic strategy to improve lung development in CDH patients.
  • This study provides novel insights into the molecular mechanisms underlying CDH lung hypoplasia using an unbiased proteomics approach.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...